BENECCHI CHRISTOPHER (Chief Commercial Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/15/2024ACC: 0001562180-24-001334
Officer· Chief Commercial Officer
Since Sep 2021
+40.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
40.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.50K
Price / share
—
Trade value
—
% of position
227.7%
2/13/2024
5.93K→19.43K
Total
Net shares
+13.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2024 | A · Award | +13.50K | — | — | 227.7% | 5.93K | 19.43K |
| Total | +13.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
27K shares
Shares
+27K
Strike price
23.02
Held after
27K
Exercisable
—
2/13/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock27K shares | 2/13/2024 | A · Award | +27K | 23.02 | — | 27K |